Active Pharmaceutical Ingredients Market Size, Share, Growth Report 2030

Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients Market By API Synthesis Segment Analysis (Biotech API, Synthetic Chemical API, HPAPI), By Type of Manufacturing Segment Analysis (Contract Manufacturing, In-House API Manufacturing), By Type of API Segment Analysis (Synthetic API, Biological API), By Drug Type Segment Analysis (Branded Drugs, Generic Drugs, OTC Drugs), By Therapeutic Application Segment Analysis (Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal, Other) : Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 12-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-56 Status : Published

Global Active Pharmaceutical Ingredients Market accounted for USD 202.90 Billion in 2020 and is expected to reach USD 101.48 Billion by 2028, growing at a CAGR of 5.1% from 2021 to 2028.

Active Pharmaceutical Ingredients Market

Market Overview

Global Active Pharmaceutical Ingredients Market accounted for USD 202.90 Billion in 2020 and is expected to reach USD 101.48 Billion by 2028, growing at a CAGR of 5.1% from 2021 to 2028.

Active Pharmaceutical Ingredient means the active ingredient which is contained in every medicine. For example, an active ingredient to relieve pain is included in a painkiller. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine. Due to the advancements in active pharmaceutical ingredient manufacturing and the increasing prevalence of chronic diseases, such as cardiovascular diseases and cancer obesity, osteoporosis, and pulmonary diseases, it has proved favorable market conditions in the active pharmaceutical ingredients market.

Holding a largely geriatric population and growing concerns of increasing chronic disorders have proved to be beneficial for the market growth. Increasing healthcare importance and infected incidences has caused measurable growth under active pharmaceutical ingredients market. Owing to the rising drug research and development activities for manufacturing, the rising importance of generics have together enhanced the market size for the active pharmaceutical ingredients market. The unfavorable drug price control policies across various nations and high manufacturing costs are expected to weaken the growth of the market.
 

COVID-19 Impact Analysis

Due to the deadly discovery of COVID-19, it had a favourable impact on the market as the countries and major manufacturing players huge amounts of ingredients to maintain the demand for the treatment of COVID 19. This has caused the drug manufacturers to redirect their focus and energy on a larger pool of patients. On the other hand, cross countries trade has become questionable and uncertain causing it to be a hindrance in the post pandemic world. Furthermore, governments of many countries have formulated plans and granted incentives to promote and support the production of API.

Due to the outbreak of the pandemic, the entire world was forced to go on a shutdown, causing factors like the shortage of labour and raw materials, and therefore ending in several problems in the manufacture of the equipment. Therefore, there is an underlying impact on the revenue of market-players, and created a huge gap in demand-supply chain.

Growth Factors

Some of the factors driving the growth of active pharmaceutical ingredients market is the increasing prevalence of chronic disorders care and support, older population, high investment in the department of research and development, increased spending on the healthcare, growing incidence of COVID-19 cases, and the inevitable technological advancements. In the recent past, the incidence of chronic diseases such as diabetes, coronary artery disease, chronic obstructive pulmonary disease (COPD), asthma, hepatitis, arthritis, and cancer has increased significantly in major regions across the globe. This can be attributed to the rising geriatric population across the globe, changing lifestyles, and dietary changes as a result of rapid urbanization.

Hence, there is an impulsive need for the active pharmaceutical ingredients in the pandemic-stricken world of today. The anticipated growth in the market is promising for the forecasted period.

Report Scope:

Report Attribute Details
Base Year 2022
Historic Years 2018 - 2022
Forecast Years 2023 - 2030
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2023 to 2030
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

 

Drug Type Segment Analysis Preview

On the basis of type of drug, the active pharmaceutical ingredients market is segmented into branded drugs, general drugs and over-the-counter drugs. As per latest study, branded drugs segment is dominating the active pharmaceutical ingredients market because of high cost of the drugs which will increase the APIs and manufacturing cost of the APIs.

Due to the rising cost of healthcare, governments and investors are pushing for increasing generics consumption over branded drugs, thus driving the growth of generic APIs market, in the predicted period. Additionally, several major pharmaceutical companies are also focusing on generic drugs along with branded drugs due to valid reasons like eroding product pipeline and patent expirations.

API Synthesis Segment Analysis Preview

The synthetic API segment holds a dominance due to the higher availability of raw materials and easier protocols for the synthesis of these molecules. Many synthetic molecules are also anticipated to go off-patent in the coming years, which indirectly caters to the growth.

The biotech segment is expected to expand over the forecast period, driven by factors such as increasing demand for biopharmaceuticals and higher efficiency of these molecules. Furthermore, the growth of the biotech segment can be attributed to high investments in the biotechnology sectors. This allows the innovation of new molecules that aid in the treatment of diseases, such as cancer.

Therapeutic Application Type Segment Analysis Preview

On the basis of therapeutic application, the market is bifurcated into Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal, Others. The cardiology diseases segment accounts to be the largely beneficial, attributed to the increasing prevalence of target diseases worldwide. Various organizations such as the World Heart Federation, the World Stroke Organization are working toward increasing awareness about cardiology diseases.

Many government initiatives programs are aimed at improving awareness related to cholesterol-related diseases. Increasing awareness about cardiology diseases and high prevalence are anticipated to drive the segment over the forecast period, thus driving demand for APIs for cardiology drugs. Although, oncology is expected to be the fastest-growing application segment with due consideration to factors such as changing lifestyles and the growing prevalence of cancer.

Regional Analysis Preview

Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and Rest of the World. In recent times, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia Pacific. The reason for North America’s dominance in the global market is attributed to the rising incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for specialty drugs, and technological advancements in the manufacturing processes of APIs.

During the forecasted period, Asia Pacific is anticipated to have an accelerated growth. The presence of economies like China and India among the Asia Pacific, which the world relies on for low-cost API production, is a benefit for the region. The market is expected to rise due to rising healthcare expenditure in the region.

Key Market Players & Competitive Landscape

Some of the leading players in the market are Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd.

The global home Active pharmaceutical ingredients market is segmented as follows:

By Synthesis Segment Analysis:

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

By Manufacturing Type Segment Analysis:

  • Contract Manufacturing
  • In-House API Manufacturing

By API Type Segment Analysis:

  • Synthetic API
  • Biological API

By Drug Type Segment Analysis:

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

By Therapeutic Application Segment Analysis:

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal
  • Other

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The global Active Pharmaceutical Ingredients market was valued at USD 202.90 Billion in 2020.

The global Active Pharmaceutical Ingredients market is expected to reach USD 101.48 Billion by 2028, growing at a CAGR of 5.1% between 2021 to 2028.

Some of the factors driving the growth of active pharmaceutical ingredients market is the increasing prevalence of chronic disorders care and support, older population, high investment in the department of research and development, increased spending on the healthcare, growing incidence of COVID-19 cases, and the inevitable technological advancements. In the recent past, the incidence of chronic diseases such as diabetes, coronary artery disease, chronic obstructive pulmonary disease (COPD), asthma, hepatitis, arthritis, and cancer has increased significantly in major regions across the globe. This can be attributed to the rising geriatric population across the globe, changing lifestyles, and dietary changes as a result of rapid urbanization.

Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and Rest of the World. In recent times, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia Pacific. The reason for North America’s dominance in the global market is attributed to the rising incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for specialty drugs, and technological advancements in the manufacturing processes of APIs.

Some of the leading players in the market are Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla, Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed